R W Luebke, M M Riddle, R R Rogers, D G Rowe, R J Garner, R J Smialowicz
{"title":"Immune function in adult C57BL/6J mice following exposure to urethan pre- or postnatally.","authors":"R W Luebke, M M Riddle, R R Rogers, D G Rowe, R J Garner, R J Smialowicz","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Administration of urethan (URE or ethyl carbamate) to mice results in the development of a variety of tumors, and, in certain strains of mice, marked suppression of the immune response. Perinatal exposure of mice to URE has been found to result in increased tumor induction compared to exposure of adult animals. In the present study, the effects of perinatal exposure to URE on the development of immunocompetence was investigated. Pregnant mice were injected with total doses of either 0.5 or 1.0 mg URE/g of body weight over days 7-16 of gestation or pups of nontreated dams were administered a total dose of 2.0 mg URE/g of body weight over postpartum days 5-14. Postnatal exposure to URE suppressed NK (natural killer) cell activity but left intact other measured parameters of the host defense system. Prenatal exposure, on the other hand, resulted in elevated leukocyte counts and a trend toward increased spleen and thymus size in offspring of treated mothers. Humoral immune function, as measured by the IgM response to sheep erythrocytes, was suppressed in pups from dams injected with a total of 1.0 mg/g URE. These results indicate that marked differences in immunopharmacologic effects may be observed if chemical exposure occurs at different times during the ontogeny of the immune system.</p>","PeriodicalId":16049,"journal":{"name":"Journal of immunopharmacology","volume":"8 2","pages":"243-57"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14841813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Suppression of spontaneous insulin-dependent diabetes in BB rats by administration of ciamexone.","authors":"U Kiesel, K Maruta, U Treichel, U Bicker, H Kolb","doi":"10.3109/08923978609026496","DOIUrl":"https://doi.org/10.3109/08923978609026496","url":null,"abstract":"<p><p>BB rats spontaneously develop an insulin dependent diabetes which resembles in many features human type I diabetes. We have tested the effect of the immunomodulatory drug Ciamexone, a 2-cyan-aziridine-derivative, on the development of diabetes in BB rats. Ciamexone was given once daily during 6 days per week beginning with the age of 42 or 50 days up to 120 days. For comparison cyclosporin A (10 mg/kg) was applied following the same protocol. At 1 mg/kg ciamexone administration led to complete prevention of diabetes in females but was not beneficial in males. At 10 mg/kg the drug caused significant suppression of diabetes development in males but more pronounced in females. Both, a reduction of the incidence of diabetes and a delay in the onset of hyperglycaemia was observed only in females. After administration of cyclosporin A none of the animals developed diabetes. Ciamexone treatment did not affect granulocyte and lymphocyte counts and subsets in the peripheral blood except for a tendency to suppress eosinophilia. The growth of animals was not retarded. It is concluded that ciamexone seems to influence the autoimmune state of the BB rat resulting in partial suppression of the disease.</p>","PeriodicalId":16049,"journal":{"name":"Journal of immunopharmacology","volume":"8 3","pages":"393-406"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08923978609026496","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14878340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R. Luebke, M. Riddle, R. Rogers, D. G. Rowe, R. Garner, R. Smialowicz
{"title":"Immune function in adult C57BL/6J mice following exposure to urethan pre- or postnatally.","authors":"R. Luebke, M. Riddle, R. Rogers, D. G. Rowe, R. Garner, R. Smialowicz","doi":"10.3109/08923978609028617","DOIUrl":"https://doi.org/10.3109/08923978609028617","url":null,"abstract":"Administration of urethan (URE or ethyl carbamate) to mice results in the development of a variety of tumors, and, in certain strains of mice, marked suppression of the immune response. Perinatal exposure of mice to URE has been found to result in increased tumor induction compared to exposure of adult animals. In the present study, the effects of perinatal exposure to URE on the development of immunocompetence was investigated. Pregnant mice were injected with total doses of either 0.5 or 1.0 mg URE/g of body weight over days 7-16 of gestation or pups of nontreated dams were administered a total dose of 2.0 mg URE/g of body weight over postpartum days 5-14. Postnatal exposure to URE suppressed NK (natural killer) cell activity but left intact other measured parameters of the host defense system. Prenatal exposure, on the other hand, resulted in elevated leukocyte counts and a trend toward increased spleen and thymus size in offspring of treated mothers. Humoral immune function, as measured by the IgM response to sheep erythrocytes, was suppressed in pups from dams injected with a total of 1.0 mg/g URE. These results indicate that marked differences in immunopharmacologic effects may be observed if chemical exposure occurs at different times during the ontogeny of the immune system.","PeriodicalId":16049,"journal":{"name":"Journal of immunopharmacology","volume":"38 2 1","pages":"243-57"},"PeriodicalIF":0.0,"publicationDate":"1986-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74590981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Immunosuppressive agents and plasmapheresis in immunological disorders.","authors":"G C Tsokos, J E Balow","doi":"10.3109/08923978509026465","DOIUrl":"https://doi.org/10.3109/08923978509026465","url":null,"abstract":"<p><p>Plasmapheresis (PA) was introduced in the treatment of immunologically mediated disease at the beginning of last decade and it was initially claimed to be the panacea for several diseases. It was quickly realized that PA on its own did not have a sustained therapeutic effect and it was the immunosuppressive drugs which could help in the maintenance of an established effect. In this communication we review the immunoregulatory effects of several immunosuppressive agents and discuss their role when used in conjunction with PA primarily in the treatment of rheumatological disorders.</p>","PeriodicalId":16049,"journal":{"name":"Journal of immunopharmacology","volume":"7 1","pages":"1-15"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08923978509026465","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15007486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
B Szende, L Kisfaludy, K Lapis, L Dénes, L Szporny, O Nyéke, I Schön, G Hajós, J Ember, M Constantin
{"title":"The effect of TP-5 and its analogs on skin grafts in mice.","authors":"B Szende, L Kisfaludy, K Lapis, L Dénes, L Szporny, O Nyéke, I Schön, G Hajós, J Ember, M Constantin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The immunostimulatory action of oligopeptides RGH-0205 (Arg-Lys-Asp), RGH-0206 (Arg-Lys-Asp-Val) and TP-5 (Arg-Lys-Asp-Val-Try) was measured using the B10LP to C57BL skin graft system and the determination of splenic T cell ratio. While thymectomy increased the period between skin grafting and rejection, each of the oligopeptides increased the number of splenic T cells and in some extent restored the rejection capacity of thymectomised C57Bl mice, presumably by restoration of thymic hormone function.</p>","PeriodicalId":16049,"journal":{"name":"Journal of immunopharmacology","volume":"7 1","pages":"67-78"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15007488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Multivariate analysis of the factors associated with the yield and purity of human monocyte isolation by countercurrent centrifugal elutriation (CCE).","authors":"P J Miller, J Beman, T Delawter, H C Stevenson","doi":"10.3109/08923978509026472","DOIUrl":"https://doi.org/10.3109/08923978509026472","url":null,"abstract":"<p><p>Substantial variability in the purity and yield of human monocytes following countercurrent centrifugal elutriation (CCE) has been reported for some time; the factors influencing this variability have not been rigorously studied in the past. Utilizing 50 normal donors, we examined several dozen preprocedural variables possibly influencing 174 separate CCE experiments, and we determined the impact of these variables on the yield and purity of monocytes obtained following cytapheresis and CCE. Donor age was not correlated with CCE monocyte yield or purity; male gender correlated with higher monocyte purity following CCE purification. The major correlates of the yield and purity of monocytes obtained by CCE were the numbers and concentration of monocytes found in the leukocyte population entered into the elutriator apparatus. Fifty-eight percent of all donors gave a very consistent yield of monocytes by CCE, with a standard error from the mean of less than 15% over the 3 years of this study. All donors consistently gave fractions with a high percentage of monocytes, with the standard error of the mean CCE monocyte purity being less than 5% over the duration of the study. Thus, while the purity of monocytes collected by CCE is highly reproducible, the yield of monocytes by this procedure is somewhat less so. These monocyte purification endpoints are affected by a number of preprocedural variables centering mainly around the percentage, concentration, and total numbers of monocytes in the cytapheresis cell population.</p>","PeriodicalId":16049,"journal":{"name":"Journal of immunopharmacology","volume":"7 1","pages":"99-123"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08923978509026472","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15122243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In vitro stimulation of macrophages by quadrol [N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine].","authors":"M V Bhide, S Patel, E C Rowland, D J Smith","doi":"10.3109/08923978509026478","DOIUrl":"https://doi.org/10.3109/08923978509026478","url":null,"abstract":"<p><p>Mouse peritoneal macrophages, when exposed to Quadrol [N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine] in vitro, show a dose dependent enhanced spreading over a four-hour period. In vitro Quadrol induced phagocytosis of polystyrene beads was found to be time and concentration dependent. The rate and extent of the enhancement of phagocytosis was comparable to that observed for lipopolysaccharide and tuftsin.</p>","PeriodicalId":16049,"journal":{"name":"Journal of immunopharmacology","volume":"7 3","pages":"303-12"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08923978509026478","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15168379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Enhancement of human allogeneic cytotoxic responses by interferons.","authors":"G Inghirami, J Y Djeu, J E Balow, G C Tsokos","doi":"10.3109/08923978509026484","DOIUrl":"https://doi.org/10.3109/08923978509026484","url":null,"abstract":"<p><p>The ability of exogenous interferons (IFN) to modify human allogeneic cytotoxic responses was studied. alpha- and beta-, and gamma-IFN, enhanced the cytotoxic responses if added at early phases of the cultures. The effect of exogenous IFN was abrogated if antibody directed against the specific IFN were present in the cultures. Normal allogeneic cytotoxic responses were abrogated in the presence of any of the anti-IFN antibodies. This inhibition could be overcome if exogenous IFN of any type (alpha, beta, or gamma) was added in excess to the cultures. IFN participate in the generation of allogeneic cytotoxic lymphocytes during mixed lymphocyte culture. It seems that each of the types of IFN supports the generation of cytotoxic responses independently of the presence of an IFN of another type.</p>","PeriodicalId":16049,"journal":{"name":"Journal of immunopharmacology","volume":"7 4","pages":"403-15"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08923978509026484","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13564914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Immunomodulatory activity of Wy-18,251 (3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid).","authors":"S C Gilman, R P Carlson, A J Lewis","doi":"10.3109/08923978509026471","DOIUrl":"https://doi.org/10.3109/08923978509026471","url":null,"abstract":"<p><p>The in vitro and in vivo effects of the experimental immunomodulatory agent Wy-18,251 (3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid) were studied in comparison with levamisole and indomethacin. Levamisole (4 mg/kg, i.v.) but not Wy-18,251 (less than or equal to 10 mg/kg, i.v.) enhanced carbon clearance rates in vivo in mice. Both Wy-18,251 and levamisole (100 mg/kg, p.o.) significantly suppressed the symptoms of experimental allergic encephalomyelitis (EAE) in rats injected with spinal cord emulsion, but neither were as effective as tilorone in this model. Wy-18,251 and levamisole (1-100 mg/kg, p.o.) suppressed the in vivo generation of plaque-forming cells (PFC) in mice immunized with sheep red blood cells while indomethacin (9 mg/kg, p.o.) enhanced PFC formation. All 3 agents (10(-5) - 10(-6) M) enhanced the in vitro ovalbumin (OA)-specific and Con A- or PHA-induced proliferative response and Con A-stimulated interleukin 2 (IL-2) synthesis of rat spleen cells. Furthermore, in vivo treatment of rats with 1-10 mg/kg (p.o.) of Wy-18,251 and levamisole but not indomethacin increased the subsequent in vitro mitogen or antigen (OA) responsiveness of spleen cells. None of the drugs (10(-5) - 10(-7) M) influenced the natural killer cell (NK) activity of rat spleen cells when incorporated directly into the 51Cr release NK assay.</p>","PeriodicalId":16049,"journal":{"name":"Journal of immunopharmacology","volume":"7 1","pages":"79-98"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08923978509026471","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14990106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effects of Wy-18,251 (3-p-chlorophenyl)thiazolo[3,2-a]benzimidazole- 2-acetic acid), levamisole and indomethacin on the generation of murine T suppressor cells in vitro.","authors":"C M Rogers, T J Rogers, S C Gilman","doi":"10.3109/08923978509026489","DOIUrl":"https://doi.org/10.3109/08923978509026489","url":null,"abstract":"<p><p>In vitro culture of normal BALB/c spleen cells with staphylococcal enterotoxin B (SEB) activates antigen non-specific suppressor T cells (Ts) which can be assayed by their ability to suppress antibody production in a plaque assay. Addition of the experimental immunomodulatory drug Wy-18,251 (10-100 microM) to cultures of spleen cells plus SEB significantly increased Ts activity relative to cultures without the drug. Similar results were obtained with levamisole, but, in contrast, indomethacin (0.1-10 microM) inhibited SEB-induced suppressor cell activity. The ability of Wy-18,251 to augment Ts activity could be therapeutically useful in the treatment of those autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus, in which hyperactive B cell function is a characteristic feature.</p>","PeriodicalId":16049,"journal":{"name":"Journal of immunopharmacology","volume":"7 4","pages":"479-88"},"PeriodicalIF":0.0,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3109/08923978509026489","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14071947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}